Patients with an early form of breast cancer are less likely to suffer a recurrence if they are post-menopausal or if their tumour is oestrogen receptor positive, according to research presented at ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Women diagnosed with ductal carcinoma in situ (DCIS) are frequently confused about the diagnosis, unclear about whether it is cancer or not, and have lingering concerns about how and why they chose to ...
Thirty-day all-cause readmission rate at a cancer center as a quality of care measure.
Amanda MacMillan is a health and science writer and editor. Her work appears across brands like Health, Prevention, SELF, O Magazine, Travel + Leisure, Time Out New York, and National Geographic's The ...
Ductal carcinoma in situ (DCIS) represents pre-invasive breast carcinoma. In untreated cases, 25–60% DCIS progress to invasive ductal carcinoma (IDC). The challenge lies in distinguishing between ...
Before breast screening with mammography became routine, ductal carcinoma in situ (DCIS) and high-risk breast lesions were rarely found. Now with the widespread use of mammography, those breast ...
A diagnosis of ductal carcinoma in situ (DCIS) might seem reassuring compared to invasive breast cancer, but recent research paints a more nuanced picture about this condition that affects roughly ...
DCIS, often called Stage Zero breast cancer, is the earliest stage and often diagnosed via mammogram, with no symptoms. In most cases, DCIS will not turn into a life-threatening tumor, but doctors ...
A team of researchers mapping a molecular atlas for ductal carcinoma in situ (DCIS) has made a major advance toward distinguishing whether the early pre-cancers in the breast will develop into ...
Immunofluorescence multiplexing (MxIF) was used to image and quantify 32 cellular biomarkers in FFPE DCIS tissue microarrays. Over 75,000 DCIS cells from 51 patients (median 9 years follow-up for ...
A team of researchers mapping a molecular atlas for ductal carcinoma in situ (DCIS) has made a major advance toward distinguishing whether the early pre-cancers in the breast will develop into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results